Study
In recent years, Rayonex Biomedical has conducted various studies on bioresonance according to Paul Schmidt. Probably the most significant is the new clinical-prospective, double-blind randomised & placebo-controlled study on pain reduction in patients with cervical spine syndrome. It proves that bioresonance according to Paul Schmidt literally works with waves of success.
In the case of neck pain, headaches, back pain and tension, no significant improvement was achieved under placebo treatment. When treated with the Rayocomp bioresonance device, all parameters showed significant improvements.
With this scientific study there is now proof for patient and therapist of a safe and effective application of bioresonance according to Paul Schmidt. The result of the study thus proves what our users have already been confirming to us for decades: Bioresonance therapy according to Paul Schmidt alleviates complaints and helps patients to achieve a new sense of health and well-being.
SCIENTIFICALLY PROVEN EFFICACY
Significant Improvements
"The Rayocomp PS 1000 polar 4.0 bioresonance device achieved significant improvements in all objective and subjective parameters of the study when compared to the placebo device."
Study participants
High recommendation rates
„Overall, there were significant differences in how patients answered the question of whether they would recommend the treatment to others. All patients in the Rayocomp group said that they would recommend it, while only around a quarter of patients in the placebo group said the same.“
ASSESSMENT OF THE THERAPY |
CONTROL GROUP (PLACEBO) |
EXPERIMENTAL GROUP (RAYOCOMP) |
||
|---|---|---|---|---|
| Number (n) | Proportion % | Number (n) | Proportion % | |
| Therapy recommendation | 6 | 26,1% | 24 | 100,0% |
| No recommendation of the therapy | 17 | 73,9% | 0 | 0,0% |
FROM THE FINAL CLINICAL REPORT BY DR. HANS WERNER VOSS, PUBLISHED IN THE BOOK “SUCCESSFUL TREATMENT OF CHRONIC PAIN” BY RAYONEX BIOMEDICAL GMBH FROM THE YEAR 2020.
Our medical devices
Medical application of bioresonance according to Paul Schmidt with approved class I and class IIa medical products for clinics, medical practitioners, alternative practitioners, therapists and, of course, home use.
Rayocomp PS 1000 polar 4.0 med.
Development costs of approx. 3.5 million euros were invested in the development and approval in order to meet the current medical product standards. The evolution within bioresonance according to Paul Schmidt – Made in Germany.
Rayocomp PS 10 med.
Despite its small dimensions, our Rayocomp PS 10 med. has it all – this is an excellent and robust companion not only for mobile use – of course “Made in Germany”.
Further studies & scientific papers
Fraunhofer
Efficacy study on the device systems of Rayonex Biomedical GmbH.
In vitro studies on the activation of cell metabolism in organic-specific cell cultures with the Mini-Rayonex
